Global /South Korea /Healthcare /Biotechnology /222110

PanGen Biotech Inc.

222110

• KRX: 222110 • Delayed

6,000KRW -0.2%

3.91 USD

As of 5 June 2026, PanGen Biotech Inc. has a market cap of $52.67M USD, ranking #30238 globally and #1703 in South Korea. It ranks #2741 in the Healthcare sector, and #530 in the Biotechnology industry.

Global Rank

30238

Country Rank

1703

Sector Rank

2741

Industry Rank

530

Key Stats

Market Cap

$52.67MUSD

80.97B KRW

Enterprise Value

$44.44MUSD

68.12B KRW

Revenue (TTM)

$8.73MUSD

13.42B KRW

EBITDA (TTM)

$1.94MUSD

2.97B KRW

Net Income (TTM)

$1.33MUSD

2.05B KRW

EBITDA Margin

22%

Profit Margin

15%

PE Ratio

41.1

PS Ratio

6.0

PB Ratio

2.7

EV/EBITDA

22.9

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

Founded

1999

Website

pangen.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	-1.2%	9.3%	6.8%	-1.5%	7.3%	5.8%	-0.7%	-36%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	222110 (주)팬젠 ISIN: KR7222110009 Shares Out.: Shares Outstanding: 13.515M¹ Shares Float: 7.204M² TV: TradingView: KRX: 222110 SA: Stock Analysis: KRX: 222110 YF: Yahoo Finance: 222110.KS GF: Google Finance: KRX: 222110 BA: Barron's: 222110 MS: Morningstar: XKRX: 222110	6,000 KRW	TV: TradingView: KRX: 222110 SA: Stock Analysis: KRX: 222110 YF: Yahoo Finance: 222110.KS GF: Google Finance: KRX: 222110 BA: Barron's: 222110 MS: Morningstar: XKRX: 222110

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PanGen Biotech Inc.

PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.36B 68.19T KRW 84K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$27.81B 42.76T KRW 53K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.23B 20.33T KRW 25K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.45B 8.37T KRW 10K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.95B 6.07T KRW 7K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.23B 3.42T KRW 4K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 346K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 304K%	19.0	United States
argenx SE EBR: ARGX	$48.01B 41.39B EUR 91K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$42.98B 60.27B AUD 81K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.55B 33.71B CHF 81K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 52K%	-	United States

chevron_leftBack